Details of the Drug

General Information of Drug (ID: DMU3KIF)

• Drug Name: CTX-4430

Indication

Disease Entry	ICD 11	Status	REF
Cystic fibrosis	CA25	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 68488178
  TTD ID: D0Z0ZT

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)